Although decreased ST6Gal1 may increase EGF-induced EGFR phosphorylation and ERK1/2 activation in CRC cells [96], NDAT has been shown to reduce ERK1/2 activation and ST6Gal1 accumulation in CRC cells [5]. This evidence concerns the gene MAPK3 and colorectal carcinoma.